Intech Biopharm Corporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 16.684 million compared to TWD 17.200 million a year ago. Operating loss was TWD 299.707 million compared to TWD 230.952 million a year ago. Net loss was TWD 311.424 million compared to TWD 222.075 million a year ago. Basic loss per share was TWD 3.82 compared to TWD 2.86 a year ago.